Richard Aguilar

743 total citations
13 papers, 514 citations indexed

About

Richard Aguilar is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Richard Aguilar has authored 13 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Richard Aguilar's work include Diabetes Treatment and Management (9 papers), Diabetes Management and Research (7 papers) and Pancreatic function and diabetes (5 papers). Richard Aguilar is often cited by papers focused on Diabetes Treatment and Management (9 papers), Diabetes Management and Research (7 papers) and Pancreatic function and diabetes (5 papers). Richard Aguilar collaborates with scholars based in United States, Germany and Thailand. Richard Aguilar's co-authors include Stanley S. Schwartz, Barbara E. Corkey, Struan F.A. Grant, Solomon Epstein, James R. Gavin, Pamela Kushner, Charles F. Shaefer, Mary E. Herman, James R. Gavin and Wing Chow and has published in prestigious journals such as Ecology, Diabetes Care and Trends in Endocrinology and Metabolism.

In The Last Decade

Richard Aguilar

13 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Aguilar United States 8 324 169 148 91 71 13 514
Hitoshi Kuwata Japan 16 591 1.8× 268 1.6× 217 1.5× 120 1.3× 55 0.8× 44 746
Amelia K. Fotheringham Australia 11 243 0.8× 157 0.9× 103 0.7× 84 0.9× 56 0.8× 20 567
Chaoxun Wang China 9 259 0.8× 133 0.8× 80 0.5× 63 0.7× 54 0.8× 15 499
Andrew Vick United States 13 235 0.7× 229 1.4× 144 1.0× 67 0.7× 55 0.8× 17 608
Silvia Magno Italy 16 153 0.5× 179 1.1× 151 1.0× 149 1.6× 76 1.1× 29 537
Alessandra Melis Italy 11 294 0.9× 110 0.7× 223 1.5× 81 0.9× 40 0.6× 32 615
Jennifer Taher Canada 16 213 0.7× 174 1.0× 133 0.9× 131 1.4× 20 0.3× 36 562
Antonio Rossi Italy 11 220 0.7× 94 0.6× 106 0.7× 111 1.2× 44 0.6× 29 442
Julie Amyot Canada 6 189 0.6× 195 1.2× 312 2.1× 120 1.3× 120 1.7× 7 521
Dalva Marreiro Rocha Brazil 8 224 0.7× 115 0.7× 179 1.2× 169 1.9× 74 1.0× 15 521

Countries citing papers authored by Richard Aguilar

Since Specialization
Citations

This map shows the geographic impact of Richard Aguilar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Aguilar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Aguilar more than expected).

Fields of papers citing papers by Richard Aguilar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Aguilar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Aguilar. The network helps show where Richard Aguilar may publish in the future.

Co-authorship network of co-authors of Richard Aguilar

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Aguilar. A scholar is included among the top collaborators of Richard Aguilar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Aguilar. Richard Aguilar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Aguilar, Richard, et al.. (2020). Current Understanding of COVID-19 Clinical Course and Investigational Treatments. Frontiers in Medicine. 7. 555301–555301. 23 indexed citations
2.
Miller, Eden, Richard Aguilar, Mary E. Herman, & Stanley S. Schwartz. (2019). Type 2 diabetes: Evolving concepts and treatment. Cleveland Clinic Journal of Medicine. 86(7). 494–504. 6 indexed citations
3.
Schwartz, Stanley S., Solomon Epstein, Barbara E. Corkey, et al.. (2017). A Unified Pathophysiological Construct of Diabetes and its Complications. Trends in Endocrinology and Metabolism. 28(9). 645–655. 81 indexed citations
4.
Aguilar, Richard, et al.. (2017). HbA 1c Outcomes in Patients Treated With Canagliflozin Versus Sitagliptin in US Health Plans. Clinical Therapeutics. 39(10). 2061–2072. 5 indexed citations
5.
Chow, Wing, et al.. (2016). Real-world evaluation of glycemic control among patients with type 2 diabetes mellitus treated with canagliflozin versus dipeptidyl peptidase-4 inhibitors. Current Medical Research and Opinion. 32(6). 1087–1096. 19 indexed citations
6.
Schwartz, Stanley S., Solomon Epstein, Barbara E. Corkey, et al.. (2016). The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema. Diabetes Care. 39(2). 179–186. 221 indexed citations
7.
Shaefer, Charles F., Pamela Kushner, & Richard Aguilar. (2015). User’s guide to mechanism of action and clinical use of GLP-1 receptor agonists. Postgraduate Medicine. 127(8). 818–826. 90 indexed citations
8.
Chow, Wing, Erin Buysman, Marcia F.T. Rupnow, Richard Aguilar, & Henry J. Henk. (2015). Canagliflozin treatment of Hispanic and non-Hispanic patients with type 2 diabetes in a US managed care setting. Current Medical Research and Opinion. 32(1). 13–22. 6 indexed citations
9.
Lajara, Rosemarie, Richard Aguilar, Uwe Hehnke, Hans‐Juergen Woerle, & Maximilian von Eynatten. (2014). Efficacy and Safety of Linagliptin in Subjects With Long-standing Type 2 Diabetes Mellitus (>10 Years): Evidence From Pooled Data of Randomized, Double-blind, Placebo-controlled, Phase III Trials. Clinical Therapeutics. 36(11). 1595–1605. 11 indexed citations
10.
Davidson, Jaime A., Rosemarie Lajara, Richard Aguilar, et al.. (2014). Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials. BMJ Open Diabetes Research & Care. 2(1). e000020–e000020. 7 indexed citations
11.
Aguilar, Richard. (2012). Managing type 2 diabetes in men.. PubMed. 61(6 Suppl). S16–21. 5 indexed citations
12.
13.
Kieft, Thomas L., Carleton S. White, Samuel R. Loftin, et al.. (1998). Temporal Dynamics in Soil Carbon and Nitrogen Resources at a Grassland-Shrubland Ecotone. Ecology. 79(2). 671–671. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hitoshi Kuwata Breakdown of academic impact, for papers by Amelia K. Fotheringham Breakdown of academic impact, for papers by Chaoxun Wang Breakdown of academic impact, for papers by Andrew Vick Breakdown of academic impact, for papers by Silvia Magno Breakdown of academic impact, for papers by Alessandra Melis Breakdown of academic impact, for papers by Jennifer Taher Breakdown of academic impact, for papers by Antonio Rossi Breakdown of academic impact, for papers by Julie Amyot Breakdown of academic impact, for papers by Dalva Marreiro Rocha
Rankless by CCL
2026